31 July 2014 - Deborah Wilkes
Archived
Sweden's Meda is set to strengthen its presence in the consumer healthcare market by acquiring privately-owned Italian company Rottapharm Madaus in a cash and shares deal worth SEK21.2 billion (US$3.08 billion).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.